Key result
Appropriate medical therapy is linked to up to ~70% of mortality reductions in elderly CVD.
Why the study?
Does high regional use of appropriate medical therapies reduce disability and death in elderly patients with cardiovascular disease?
Cohort
Does high regional use of appropriate medical therapies reduce disability and death in elderly patients with cardiovascular disease?
Increased use of evidence-based cardiovascular therapies significantly contributed to population-level declines in disability and mortality among the elderly.
Supports prioritizing evidence-based therapies in elderly CVD; extends trend analyses but remains hypothesis-generating from observational data.
There is little empirical evidence to explain why disability declined among the elderly over the past 20 years. In this paper, we explore the role of improved medical care for cardiovascular disease on health status improvements over time. We show that the incidence of cardiovascular disease hospitalizations remained relatively constant between 1984 and 1999 at the same time that post-event survival improved and disability declined. We find that use of appropriate therapies, including pharmaceuticals such as beta-blockers, aspirin, and ace-inhibitors, and invasive procedures, explains up to 50% and 70% of the reductions in disability and death over time, respectively. Elderly patients living in regions with high use of appropriate medical therapies had better health outcomes than patients living in low-use areas. Finally, we estimate that preventing disability after an acute event can add as much as 3.7 years of quality-adjusted life expectancy, or $316,000 of value.
No takes yet. Share an insight, caveat, or question.
Cutler et al. (2006) conducted a cohort in Cardiovascular disease. Appropriate medical therapies (pharmaceuticals and invasive procedures) vs. Low regional use of appropriate medical therapies was evaluated on Reductions in disability and death. Use of appropriate medical therapies explained up to 50% and 70% of the reductions in disability and death over time, respectively, among elderly patients with cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: